Developing a Kidney Waiting List Calculator

Similar documents
Karnofsky Performance Score and Its Use in Risk Adjustment of Transplant Outcomes in the United States

The Good, The Bad, The Needs: Current Prediction Methods Used in Program Specific Reports

Embracing the Magic: Increasing Organ Acceptance Rates Through Data Review and Risk Stratification

A risk quantification score for heart transplants: A heart donor risk index (HDRI)

Influence of kidney offer acceptance behavior on metrics of allocation efficiency

FAIRNESS/EQUITY UTILITY/EFFICACY EFFICIENCY. The new kidney allocation system (KAS) what has it done? 9/26/2018. Disclosures

Update on Kidney Allocation

kidney OPTN/SRTR 2012 Annual Data Report:

Are two better than one?

Scores in kidney transplantation: How can we use them?

Access and Outcomes Among Minority Transplant Patients, , with a Focus on Determinants of Kidney Graft Survival

The New Kidney Allocation Policy: Implications for Your Patients and Your Practice

The Kidney Allocation System Changed in a Substantive Way on December 5, Your Patients Have Been, and Will Be, Affected by These Changes

The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health

User Guide. A. Program Summary B. Waiting List Information C. Transplant Information

OPTN/SRTR 2014 ANNUAL DATA REPORT

New National Allocation Policy for Deceased Donor Kidneys in the United States and Possible Effect on Patient Outcomes

Kidney Transplant Outcomes In Elderly Patients. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania

Chapter 6: Transplantation

OPTN/SRTR 2015 Annual Data Report: Deceased Organ Donation

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly?

Program- specific transplant rate ratios: Association with allocation priority at listing and posttransplant outcomes

OPTN/SRTR 2016 Annual Data Report: Preface

Progress in Pediatric Kidney Transplantation

Minutes. SRTR Visiting Committee

Liver Sharing and Organ Procurement Organization Performance

Transplant Nephrology Update: Focus on Outcomes and Increasing Access to Transplantation

Renal Transplantation: Allocation challenges and changes. Renal Transplantation. The Numbers 1/13/2014

Early Changes in Kidney Distribution under the New Allocation System

Living Donor Paired Exchange (LDPE)

Current status of kidney and pancreas transplantation in the United States,

The New Kidney Allocation System (KAS) Frequently Asked Questions

Kidney, Pancreas and Liver Allocation and Distribution

Future Approaches to Organ Donor Intervention Research Study Design. Bertram Kasiske, MD Project Director, SRTR December 14, 2016

Association of Kidney Transplantation with Survival in Patients with Long Dialysis Exposure

The New Kidney Allocation System: What You Need to Know. Quality Insights Renal Network 3 Annual Meeting October 2, 2014

Kidney and Pancreas Transplantation in the United States, : Access for Patients with Diabetes and End-Stage Renal Disease

Broader Geographic Sharing of Pediatric Donor Lungs Improves Pediatric Access to Transplant

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

Three Sides to Allocation. ECD Extended Criteria Donor

Kidney Allocation- Will it ever be fair? Peter G Stock MD, PhD UCSF Department of Surgery. Would you accept this offer?

KIDNEY & PANCREAS TRANSPLANT OUTCOMES 2018

LUNG ALLOCATION SCORE SYSTEM UPDATE

Debate: HLA matching matters in children

National Transplant Guidelines

LIVE KIDNEY DONOR RISK PREDICTION ; NEW PARADIGM, NEW CALCULATORS PEDRAM AHMADPOOR MD

Concepts for Kidney Allocation

Geographic Differences in Event Rates by Model for End-Stage Liver Disease Score

Kidney Transplantation in the Elderly. Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo

Does Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality donor kidneys?

Transplant Program Performance Measures Review Outcome Measures Work Group Update. Membership and Professional Standards Committee December 2015

Kidney and Pancreas Transplantation in the United States,

Offer Acceptance Practices and Geographic Variability in Allocation Model for End-Stage Liver Disease at Transplant

Why are Donated Kidneys Rejected While the Transplant Waiting List is Long and Growing?

The Art and Science of Increasing Authorization to Donation

Donor Quality Assessment

Donation from Old Living Donors How safe is it? Safe for recipient or donor?

Chapter 7. Australian Waiting List. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Deceased Organ Transplant Waiting List SECTION 11

Transplant Options for Patients: Choices and Consequences. Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital

Kidney Transplant in the Elderly. Robert Santella, M.D., F.A.C.P.

Organ Waiting Lists in Australia and New Zealand

We have no disclosures

Quantification of the Early Risk of Death in Elderly Kidney Transplant Recipients

Transplant Update New Kidney Allocation System Transplant Referral Strategies. Antonia Harford, MD University of New Mexico

Københavns Universitet

Simultaneous Pancreas Kidney Transplantation:

Peripheral arterial disease (PAD) is a major complication

A Lifetime of Allograft Function with Kidneys from Older Donors

HLA Amino Acid Polymorphisms and Kidney Allograft Survival. Supplemental Digital Content

Implications of the Statewide Sharing Variance on Kidney Transplantation Geographic Inequity and Allocation Efficiency

SELECTED ABSTRACTS. All (n) % 3-year GS 88% 82% 86% 85% 88% 80% % 3-year DC-GS 95% 87% 94% 89% 96% 80%

Donor-derived Cell-free DNA Improves DSA-informed Diagnosis of ABMR in Kidney Transplant Patients

Final Report: Update on Prior Living Donors Who Were Subsequently Placed on the Waiting List

U.S. changes in Kidney Allocation

For more information about how to cite these materials visit

Prevalence and Outcomes of Multiple-Listing for Cadaveric Kidney and Liver Transplantation

A Guide to Better Living

Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia

Liver and intestine transplantation: summary analysis,

KIDNEY TRANSPLANTATION IS THE

Clinical correlates, outcomes and healthcare costs associated with early mechanical ventilation after kidney transplantation

Social deprivation, ethnicity and access to kidney transplantation in England and Wales. Udaya Udayaraj

Welcome to Your DSA Action Team Meeting. February 29, 2012

Understanding Pharmaceutical Care Needs of Living Kidney Donors through Linked Transplant Registry and Pharmacy Claims Data

Use of HCV + Donors Should Be Considered Standard of Care

heart OPTN/SRTR 2013 Annual Data Report:

KIDNEY TRANSPLANTATION: THE BIG PICTURE

Shipping living donor kidneys and transplant recipient outcomes

Literature Review Transplantation

Organ Procurement and Transplantation Network

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

CURRENT ALLOCATION POLICIES AND DISPARITIES WITHIN LIVER AND KIDNEY TRANSPLANTATION. Minja Gosto. BS, Allegheny College, 2010

Perverse Incentive System How Regulations and Perceptions are: - Costing Lives - Wasting Dollars - Dishonoring the Gift of Donation

Recycle Yourself. Facts about organ, eye and tissue donation

Are Your Patients Well Prepared for Kidney Transplant?

Healthcare Disparities and Need for Transplant in our Multicultural Communities

Prelisting Prescription Narcotic Use: Survival Implications in Liver Transplantation

KIDNEY ALLOCATION SYSTEM (KAS) OUT-OF-THE-GATE MONITORING. Report #3: January 13, 2015

Transcription:

Developing a Kidney Waiting List Calculator Jon J. Snyder, PhD* Nicholas Salkowski, PhD, Jiannong Liu, PhD, Kenneth Lamb, PhD, Bryn Thompson, MPH, Ajay Israni, MD, MS, and Bertram Kasiske, MD, FACP *Presenter

The 12 th Joint Annual Congress of the American Society of Transplant Surgeons and The American Society of Transplantation Jon J. Snyder, PhD Senior Epidemiologist Scientific Registry of Transplant Recipients, Minneapolis, MN, USA I have no financial relationships to disclose within the past 12 months relevant to my presentation My presentation does not include discussion of off-label or investigational use.

Motivation A basic question: How long will I need to wait to receive a kidney transplant??? Some national data are available:

OPTN/SRTR 2010 Annual Data Report, Figure KI 1.7 Kidney transplant waiting list status by month post-listing among new adult listings in 2006 8% Removed from the list 10% Died 14% Transplanted (LD) 30% Transplanted (DD) 38% Still Waiting

OPTN/SRTR 2010 Annual Data Report, KI 1.10 Median years to kidney transplant for wait-listed adult patients

OPTN/SRTR 2010 Annual Data Report, KI 1.9 Median years to kidney transplant (deceased donor) for adult patients transplanted in 2009, by DSA This answers How long did people wait? rather than How long will I wait?.

SRTR OPO-Specific Reports Contain Data by DSA

What does the Kidney Calculator do? Based on candidate characteristics (including donor service area, blood type, CPRA, and willingness to accept an ECD kidney) the calculator will predict the following event probabilities for the first five years following listing: The candidate receives a living-donor transplant The candidate receives a deceased-donor transplant The candidate remains on the waiting list The candidate is removed from the waiting list The candidate dies on the waiting list or is removed from the list for being too sick for transplant

What else does the Kidney Calculator do? The kidney calculator also calculates post-transplant survival probabilities If the candidate receives a living-donor transplant If the candidate receives a deceased-donor transplant, adjusted for differences in graft quality (KDPI)

Estimating Waiting Time is Difficult The median waiting times for some DSAs are long Longer follow-up is needed, so analysis cohorts need to stretch deeper into the past The experience of past candidates may be different from what candidates today will experience, due to changes in policies, medical practice, etc. The meaning of waiting time is unclear when there are competing risks...

The Modeling Challenge: The Competing Risks Covariate Disconnect A candidate on the waiting list can be removed by different events, each of which needs to be modeled separately: Deceased-donor transplant Living-donor transplant Death (or too sick for transplant) Some other event (e.g., transplant no longer needed) When there are competing risks, a higher/lower rate may or may not be associated with increasing/decreasing event probability If a covariate increases the rate of transplant by a small amount and increases the rate of death by a large amount, the probability of transplant may decrease If a covariate decreases the rate of transplant by a small amount and decreases the rate of death by a large amount, the probability of transplant may increase

Waiting Times & Competing Risks When there are competing risks, discussing waiting times is troublesome Some candidates will experience competing events before receiving a deceased-donor transplant The probability of experiencing a competing event may eventually exceed 50%, making reporting of median waiting time difficult. It is more straightforward to discuss the probability of receiving a transplant by a particular time than to summarize the waiting times

Cumulative Incidence Stacked Cumulative Incidence Curves:

Two Example Candidates DSA 1

Deceased-Donor Survival Examples 1 Deceased Donor Survival Examples 0.9 0.8 Survival 0.7 0.6 Example 1 -- KDPI 20 Example 1 -- KDPI 80 Example 2 - KDPI 20 Example 2 -- KDPI 80 0.5 0.4 0 500 1000 1500 2000 2500 Days

Example Patient 1: 39-year-old Hispanic Male, CPRA< 20, blood type O, diabetes status unknown, 2.4 years on dialysis, overweight BMI, primary diagnosis: glomerulonephritis, albumin 3.6, no PAD, no COPD, no Malignancy, will not accept ECD. Probability of receiving a deceased donor transplant within 5-years 16.1% (DSA 1) 7.0% (DSA 2) of listing: Probability of dying or being removed from the list due to deteriorating condition prior to receiving a deceased donor 80.3% (DSA 1) 90.5% (DSA 2) transplant within 5-years of listing: 5-year survival probability if this patient received a living donor 95.90% transplant from a donor under the age of 50 today: 5-year survival probability if this patient received a living donor 95.30% transplant from a donor over the age of 50 today: 5-year survival probability if this patient received a deceased donor 94.70% transplant from a donor with a KDPI of 20% today: 5-year survival probability if this patient received a deceased donor 91.70% transplant from a donor with a KDPI of 80% today:

Conclusions Predicting waiting times is a very difficult endeavor. Models are still being investigated and the process refined. End goal is a web-based calculator that could be used to educate transplant candidates about their prospects for receiving a deceased donor kidney transplant.

Developing a Kidney Waiting List Calculator Jon J. Snyder, PhD Nicholas Salkowski, PhD, Jiannong Liu, PhD, Kenneth Lamb, PhD, Bryn Thompson, MPH, Ajay Israni, MD, MS, and Bertram Kasiske, MD, FACP

Supporting Slides

Current Models DD Transplant LD Transplant Death While Waiting Removal From the List Blood Type CPRA ECD Willingness DSA DSA Age Race DM Dialysis Time BMI DGN Albumin PAD COPD Malignancy CPRA ABO ECD Willingness DSA Age Gender Race DM Dialysis Time BMI DGN Albumin PAD COPD Malignancy DSA Age Gender Race BMI DGN Albumin PAD COPD Malignancy CPRA ECD Willingness

Competing Risks Analyses of waiting list outcomes should consider competing risks A candidate on the waiting list can be removed by different events: Deceased-donor transplant Living-donor transplant Death (or too sick for transplant) Some other event (e.g., transplant no longer needed) Experiencing one event precludes experiencing the other events. For example, if a candidate dies, then he or she will not get a transplant.

Event-specific Rates (i.e., Hazards) One way to deal with competing risks is to model the rate that each event occurs. Create models for the: Deceased-donor transplant rate Living-donor transplant rate Death (or too sick for transplant) rate Other removal rate Each of these models can take the form of a Cox Proportional Hazards Regression Model

Competing Event Probabilities The probability of experiencing one particular event depends not only on that event s rate, but also on the rates of all the competing events If the rate of death is much higher than the rate of transplant, then the probability of transplant will be low even if the rate of transplant is high The event probability is a function of the event rate and the probability remaining on the waiting list (which is a function of all the competing event rates)

Covariate Effects without Competing Risks The covariate in a Cox Proportional Hazards Regression Model explain effects on the event rate (hazard) When there are no competing risks, a higher rate implies that the probability of the event increases When there are no competing risks, a lower rate implies that the probability of the event decreases This does not hold under competing risks...

The Competing Risks Covariate Disconnect When there are competing risks, a higher/lower rate may or may not be associated with increasing/decreasing event probability If a covariate increases the rate of transplant by a small amount and increases the rate of death by a large amount, the probability of transplant may decrease If a covariate decreases the rate of transplant by a small amount and decreases the rate of death by a large amount, the probability of transplant may increase

Two Example Candidates DSA 2

Living-Donor Survival Examples 1 0.95 0.9 0.85 Living-Donor Survival Examples Survival 0.8 0.75 0.7 0.65 Example 1 -- Younger Donor Example 1 -- Older Donor Example 2 -- Younger Donor Example 2 -- Older Donor 0.6 0.55 0.5 0 500 1000 1500 2000 2500 Days

Example 2 Patient 2: 74-year-old African-American Female, 20 < CPRA < 79, blood type A, No diabetes, 10 years on dialysis, overweight BMI, primary diagnosis: hypertension, 3.6 < albumin < 5.2, no PAD, no COPD, no Malignancy, will accept ECD. Probability of receiving a deceased donor transplant within 5-years 47.9% (DSA 1) 31.1% (DSA 2) of listing: Probability of dying or being removed from the list due to deteriorating condition prior to receiving a deceased donor transplant 42.3% (DSA 1) 63.0% (DSA 2) within 5-years of listing: 5-year survival probability if this patient received a living donor 67.40% transplant from a donor under the age of 50 today: 5-year survival probability if this patient received a living donor 63.50% transplant from a donor over the age of 50 today: 5-year survival probability if this patient received a deceased donor 65.60% transplant from a donor with a KDPI of 20% today: 5-year survival probability if this patient received a deceased donor 51.10% transplant from a donor with a KDPI of 80% today: